ClinicalTrialsFinder

Respiratory Syncytial Virus (RSV) Clinical Trials in South Brisbane, Queensland

1 recruitingSouth Brisbane, Queensland, Australia

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

Respiratory Syncytial Virus (RSV)Influenza A(H5N1)
Sanofi570 enrolled6 locationsNCT07516418